Michel de Rosen
Encyclopedia
Michel de Rosen is the CEO of Eutelsat Communications and is a non-executive member of the board of directors
of ABB Ltd. He was Chief Executive Officer
and Chairman of the Board of Directors
of ViroPharma Incorporated from August 2002 to May 2008. From 1982 to 1999, de Rosen held several positions in Rhone-Poulenc
(France) and Rhone-Poulenc Rorer (USA) (now Sanofi-Aventis
), including Chief Executive Officer
from May 1995 until December 1999, and Chairman of the Board of Directors
from 1996 to 1999.
From 1976 to 1982 de Rosen was auditor at the French
Ministries of Finance
and Defense
.
de Rosen holds an MBA from the École des Hautes Études Commerciales
.
de Rosen is or has been on a number of boards:
In an interview with the British newspaper The Sunday Telegraph on 1995-10-08 he was quoted as saying that he ...sees RPR as a mixture of 'hunting' - growing the company by swooping on acquisition 'prey' - and 'farming', less glamorous but vital organic growth and development of new drugs.
Board of directors
A board of directors is a body of elected or appointed members who jointly oversee the activities of a company or organization. Other names include board of governors, board of managers, board of regents, board of trustees, and board of visitors...
of ABB Ltd. He was Chief Executive Officer
Chief executive officer
A chief executive officer , managing director , Executive Director for non-profit organizations, or chief executive is the highest-ranking corporate officer or administrator in charge of total management of an organization...
and Chairman of the Board of Directors
Board of directors
A board of directors is a body of elected or appointed members who jointly oversee the activities of a company or organization. Other names include board of governors, board of managers, board of regents, board of trustees, and board of visitors...
of ViroPharma Incorporated from August 2002 to May 2008. From 1982 to 1999, de Rosen held several positions in Rhone-Poulenc
Rhône-Poulenc
-History of the company:The Company was founded in 1928 through the merger of Société des Usines Chimiques du Rhône from Lyon and Établissements Poulenc Frères from Paris founded by Étienne Poulenc, a 19th century Parisian apothecary and brought to prominence by his second and third sons Emile...
(France) and Rhone-Poulenc Rorer (USA) (now Sanofi-Aventis
Sanofi-Aventis
Sanofi S.A. is a multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the...
), including Chief Executive Officer
Chief executive officer
A chief executive officer , managing director , Executive Director for non-profit organizations, or chief executive is the highest-ranking corporate officer or administrator in charge of total management of an organization...
from May 1995 until December 1999, and Chairman of the Board of Directors
Board of directors
A board of directors is a body of elected or appointed members who jointly oversee the activities of a company or organization. Other names include board of governors, board of managers, board of regents, board of trustees, and board of visitors...
from 1996 to 1999.
From 1976 to 1982 de Rosen was auditor at the French
France
The French Republic , The French Republic , The French Republic , (commonly known as France , is a unitary semi-presidential republic in Western Europe with several overseas territories and islands located on other continents and in the Indian, Pacific, and Atlantic oceans. Metropolitan France...
Ministries of Finance
Minister of the Economy, Finance and Industry (France)
The Minister for the Economy, Industry and Employment , or Minister of Finance for short, is one of the most prominent positions in the cabinet of France after the Prime Minister....
and Defense
Minister of Defence (France)
The Minister of Defense and Veterans Affairs is the French government cabinet member charged with running the military of France....
.
de Rosen holds an MBA from the École des Hautes Études Commerciales
HEC School of Management
HEC Paris or École des Hautes Études Commerciales de Paris is one of the foremost business schools in France and in Europe. It was created in 1881 by the Paris Chamber of Commerce and Industry on the model of French Grandes Ecoles and has progressively become one of the most selective graduate...
.
de Rosen is or has been on a number of boards:
- ABB LtdAsea Brown BoveriABB is a Swiss-Swedish multinational corporation headquartered in Zürich, Switzerland, and best known for its robotics. ABB operates mainly in the power and automation technology areas. It ranked 143rd in Forbes Ranking ....
(director, since 2002); - Aspen InstituteAspen InstituteThe Aspen Institute is an international nonprofit organization founded in 1950 as the Aspen Institute of Humanistic Studies. The organization is dedicated to "fostering enlightened leadership, the appreciation of timeless ideas and values, and open-minded dialogue on contemporary issues." The...
http://www.aspeninstitute.org (mentor) - Global Business Coalition on HIV/AIDS http://www.businessfightsaids.org (director)
- HTH Worldwide http://www.hthworldwide.com/index.html;(advisor)
- InnaPhase Corporation (director, July 2000 - September 2004)
- Pennsylvania Bio http://www.pennsylvaniabio.org/ (director)
- Ursinus CollegeUrsinus CollegeUrsinus College is a liberal arts college in Collegeville, Montgomery County, Pennsylvania.-History:1867Members of the German Reformed Church begin plans to establish a college where "young men could be liberally educated under the benign influence of Christianity." These founders were hoping to...
http://www.ursinus.edu/home.asp (trustee)
In an interview with the British newspaper The Sunday Telegraph on 1995-10-08 he was quoted as saying that he ...sees RPR as a mixture of 'hunting' - growing the company by swooping on acquisition 'prey' - and 'farming', less glamorous but vital organic growth and development of new drugs.